Top

International Urology and Nephrology

Published in:

01-08-2021 | Antibiotic | Urology - Original Paper

Miniaturized percutaneous Nephrolithotomy without antibiotic prophylaxis: a single institution experience

Authors: M. J. Schnabel, B. Rosenhammer, M. Steckermeier, H. M. Fritsche, M. Burger, P. J. Spachmann

Published in: International Urology and Nephrology | Issue 8/2021

Abstract

Purpose

To assess the feasibility of sparing routine antibiotic prophylaxis in patients without preoperative urinary tract infection (UTI) undergoing a miniaturized percutaneous nephrolithotomy (mPCNL).

Patients and Methods

A retrospective, monocentric study was conducted to evaluate the outcome of a modified perioperative antibiotic management strategy according to the principles of antibiotic stewardship (ABS). From December 2015 patients undergoing mPCNL for kidney stone with preoperative unremarkable urine culture no longer received an antibiotic prophylaxis (NoPAP). The NoPAP group was compared to mPCNL patients who received standard antibiotic prophylaxis (PAP) in the two years before. Analysis focused on postoperative complications. Logistic regression analysis was performed to identify potential risk factors.

Results

Postoperative fever occurred in 8% of the NoPAP and 9% of the PAP patients (p = 0.764). Clavien 1–3 complications did not differ between groups with 33% in the NoPAP and 41% in the PAP (p = 0.511). No Clavien 4–5 complications were seen. A (partial) staghorn stone (HR 5.587; p = 0.019) and an infectious stone component (HR 6.313; p = 0.003) were identified as significant risk factors for postoperative fever. By sparing routine antibiotic prophylaxis the overall antibiotic usage was reduced from 100% (PAP) to 9% (NoPAP).

Conclusion

Patients with negative preoperative UC, a none-staghorn stone and no history of recurrent UTI or infectious stones may not need routine antibiotic prophylaxis prior to mPCNL. A prospective validation is warranted.

Sasse A, Mertens R, Sion JP et al (1998) Surgical prophylaxis in Belgian hospitals: estimate of costs and potential savings. J Antimicrob Chemother 41:267–272CrossRefPubMed

Laxminarayan R, Duse A, Wattal C et al (2013) Antibiotic resistance—the need for global solutions. Lancet Infect Dis 13:1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9CrossRefPubMed

European Centre for Disease Prevention and Control (2018) Surveillance of antimicrobial resistance in Europe – Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. https://op.europa.eu/en/publication-detail/-/publication/aca01abb-fcf9-11e8-a96d-01aa75ed71a1/language-en

Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417–433. https://doi.org/10.1128/MMBR.00016-10CrossRefPubMedPubMedCentral

Çek M, Tandoğdu Z, Naber K et al (2013) Antibiotic prophylaxis in urology departments, 2005–2010. Eur Urol 63:386–394. https://doi.org/10.1016/j.eururo.2012.09.038CrossRefPubMed

Fisang C (2015) Urolithiasis–an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Dtsch Arztebl Int 112:83–91. https://doi.org/10.3238/arztebl.2015.0083CrossRefPubMedPubMedCentral

Seitz C, Bach T, Bader M, et al. (2018) S2k-Leitlinie zur diagnostik, therapie und metaphylaxe der urolithiasis . https://www.awmf.org/leitlinien/detail/ll/043-025.html. (Accessed 14 Aug 2019)

Türk C, Neisius A, Petrik A, et al. (2018) EAU guidelines on urolithiasis. http://uroweb.org/guideline/urolithiasis

Assimos D, Krambeck A, Miller NL et al (2016) Surgical management of stones: american urological association/endourological society guideline, PART II. J Urol 196:1161–1169. https://doi.org/10.1016/j.juro.2016.05.091CrossRefPubMed

10.

Chew BH, Miller NL, Abbott JE et al (2018) A randomized controlled trial of preoperative prophylactic antibiotics prior to percutaneous nephrolithotomy in a low infectious risk population: a report from the EDGE consortium. J Urol 200:801–808. https://doi.org/10.1016/j.juro.2018.04.062CrossRefPubMed

11.

Gravas S, Montanari E, Geavlete P et al (2012) Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol 188:843–847. https://doi.org/10.1016/j.juro.2012.05.007CrossRefPubMed

12.

Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.aeCrossRefPubMedPubMedCentral

13.

de Rosette J, Assimos D, Desai M et al (2011) The clinical research office of the endourological society percutaneous nephrolithotomy global study: indications, complications and outcomes in 5803 patients. J Endourol 25:11–17. https://doi.org/10.1089/end.2010.0424CrossRefPubMed

14.

Labate G, Modi P, Timoney A et al (2011) The percutaneous nephrolithotomy global study: Classification of complications. J Endourol 25:1275–1280. https://doi.org/10.1089/end.2011.0067CrossRefPubMed

15.

Gutierrez J, Smith A, Geavlete P et al (2013) Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol 31:1135–1140. https://doi.org/10.1007/s00345-012-0836-yCrossRefPubMed

16.

Degirmenci T, Bozkurt IH, Celik S et al (2018) Does leaving residual fragments after percutaneous nephrolithotomy in patients with positive stone culture and/or renal pelvic urine culture increase the risk of infectious complications? Urolithiasis 47:371–375. https://doi.org/10.1007/s00240-018-1063-9CrossRefPubMed

17.

Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906. https://doi.org/10.1016/j.eururo.2006.10.020CrossRefPubMed

18.

Bag S, Kumar S, Taneja N et al (2011) One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. Urology 77:45–49. https://doi.org/10.1016/j.urology.2010.03.025CrossRefPubMed

19.

Liu Y, AlSmadi J, Zhu W et al (2018) Comparison of super-mini PCNL (SMP) versus miniperc for stones larger than 2 cm: a propensity score-matching study. World J Urol 36:955–961. https://doi.org/10.1007/s00345-018-2197-7CrossRefPubMed

20.

AlSmadi J, Fan J, Zhu W et al (2018) The influence of super-mini percutaneous nephrolithotomy on renal pelvic pressure in vivo. J Endourol 32:819–823. https://doi.org/10.1089/end.2018.0239CrossRefPubMed

21.

Wu C, Hua L-X, Zhang J-Z et al (2017) Comparison of renal pelvic pressure and postoperative fever incidence between standard- and mini-tract percutaneous nephrolithotomy. Kaohsiung J Med Sci 33:36–43. https://doi.org/10.1016/j.kjms.2016.10.012CrossRefPubMed

22.

Mariappan P, Smith G, Bariol SV et al (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173:1610–1614. https://doi.org/10.1097/01.ju.0000154350.78826.96CrossRefPubMed

23.

Korets R, Graversen JA, Kates M et al (2011) Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol 186:1899–1903. https://doi.org/10.1016/j.juro.2011.06.064CrossRefPubMed

24.

Walton-Diaz A, Vinay JI, Barahona J et al (2017) Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study. Int Urol Nephrol 49:31–35. https://doi.org/10.1007/s11255-016-1457-yCrossRefPubMed

25.

Chen L, Xu Q-Q, Li J-X et al (2008) Systemic inflammatory response syndrome after percutaneous nephrolithotomy: an assessment of risk factors. Int J Urol 15:1025–1028. https://doi.org/10.1111/j.1442-2042.2008.02170.xCrossRefPubMed

26.

Gonen M, Turan H, Ozturk B et al (2008) Factors affecting fever following percutaneous nephrolithotomy: a prospective clinical study. J Endourol 22:2135–2138. https://doi.org/10.1089/end.2008.0139CrossRefPubMed

27.

Mariappan P, Smith G, Moussa SA et al (2006) One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int 98:1075–1079. https://doi.org/10.1111/j.1464-410X.2006.06450.xCrossRefPubMed

Title: Miniaturized percutaneous Nephrolithotomy without antibiotic prophylaxis: a single institution experience
Authors: M. J. Schnabel
B. Rosenhammer
M. Steckermeier
H. M. Fritsche
M. Burger
P. J. Spachmann
Publication date: 01-08-2021
Publisher: Springer Netherlands
Keywords: Antibiotic
Urinary Tract Infection
Published in: International Urology and Nephrology / Issue 8/2021
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-021-02845-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Patients and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2021

Differentiation and proliferation of spermatogonial stem cells using a three-dimensional decellularized testicular scaffold: a new method to study the testicular microenvironment in vitro

Long-term mortality of living kidney donors: a systematic review and meta-analysis

Effectiveness of renal-specific oral nutritional supplements compared with diet counseling in malnourished hemodialysis patients

Entacapone scavenges peroxynitrite and protects against kidney and liver injuries induced by renal ischemia/reperfusion in rats

Triple-disease etiology is common for LUTS in octogenarians: a neuro-urological approach

Satisfaction and genital perception after orchiectomy for prostate cancer: does the technique matter? A randomized trial

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials